Proactive Investors - Run By Investors For Investors

Ascent Industries hires financial firm to explore options

The company said it has hired Clarus Securities as financial adviser to complete a strategic review
cannabis plants
The company said there was no assurance it would pursue or execute any action or transaction

Ascent Industries Corp (CSE:ASNT) (OTCMKTS:PGTMF) announced that it has hired financial firm Clarus Securities to explore a range of strategic alternatives to strengthen the company's balance sheet and maximize its value.

"While the company is focused first and foremost on remedying the situation with Health Canada, management believes that a review of strategic alternatives will allow it to make informed decisions about the company in the interests of all stakeholders," said Blair Jordan, interim chief executive officer.

READ: Ascent Industries interim CEO Blair Jordan joins board of directors

Health Canada recently granted Ascent's subsidiary Agrima an extension until Dec. 17 after suspending and proposing to revoke its producer and dealer licenses.

The company said there was no defined timeline for the strategic review, and it could result in a number of outcomes (or none). There is "no assurance that the company will pursue or execute any specific action or transaction," the company said in a release, adding it does not intend to make any further comments on the matter unless required by law. 

Shares of Ascent were at C$0.19 on Wednesday. 

 

Contact Katie Lewis at [email protected]

Follow her on Twitter: @kelewis

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full ASNT profile View Profile

Ascent Industries Corp. Timeline

Related Articles

1540909388_Marijuana-stethoscope.jpg
October 30 2018
The firm wants to become the first publicly listed, globally focused, pure cannabis company
1542134062_Harvesting-hemp.jpg
November 13 2018
Ascent, viaThirty Eight Hemp Corp, will exploit the hemp market via its strategic relationship with AgTech Scientific
The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 30 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use